Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1980 |
|---|---|
| Erschienen: |
1980 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:142 |
|---|---|
| Enthalten in: |
Ugeskrift for laeger - 142(1980), 5 vom: 28. Jan., Seite 303-5 |
| Sprache: |
Dänisch |
|---|
| Weiterer Titel: |
Tromboseprofylakse med trombocytfunktionshaemmere. 1. Cellulaere regulationsmekanismer og farmakologiske angrebspunkter |
|---|
| Beteiligte Personen: |
Hansen, M S [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 23.04.1980 Date Revised 23.11.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM062208349 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM062208349 | ||
| 003 | DE-627 | ||
| 005 | 20231221221259.0 | ||
| 007 | tu | ||
| 008 | 231221s1980 xx ||||| 00| ||dan c | ||
| 028 | 5 | 2 | |a pubmed24n0208.xml |
| 035 | |a (DE-627)NLM062208349 | ||
| 035 | |a (NLM)6243811 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a dan | ||
| 100 | 1 | |a Hansen, M S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification |
| 246 | 3 | 3 | |a Tromboseprofylakse med trombocytfunktionshaemmere. 1. Cellulaere regulationsmekanismer og farmakologiske angrebspunkter |
| 264 | 1 | |c 1980 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.04.1980 | ||
| 500 | |a Date Revised 23.11.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Dextrans |2 NLM | |
| 650 | 7 | |a Prostaglandins |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a Thromboxane A2 |2 NLM | |
| 650 | 7 | |a 57576-52-0 |2 NLM | |
| 650 | 7 | |a Adenosine Diphosphate |2 NLM | |
| 650 | 7 | |a 61D2G4IYVH |2 NLM | |
| 650 | 7 | |a Dipyridamole |2 NLM | |
| 650 | 7 | |a 64ALC7F90C |2 NLM | |
| 650 | 7 | |a Cyclic AMP |2 NLM | |
| 650 | 7 | |a E0399OZS9N |2 NLM | |
| 650 | 7 | |a Aspirin |2 NLM | |
| 650 | 7 | |a R16CO5Y76E |2 NLM | |
| 650 | 7 | |a Sulfinpyrazone |2 NLM | |
| 650 | 7 | |a V6OFU47K3W |2 NLM | |
| 650 | 7 | |a Indomethacin |2 NLM | |
| 650 | 7 | |a XXE1CET956 |2 NLM | |
| 700 | 1 | |a Birgens, H S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 142(1980), 5 vom: 28. Jan., Seite 303-5 |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
| 773 | 1 | 8 | |g volume:142 |g year:1980 |g number:5 |g day:28 |g month:01 |g pages:303-5 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 142 |j 1980 |e 5 |b 28 |c 01 |h 303-5 | ||